Tesamorelin Certificate of Analysis (COA) Standards

A lot-specific Certificate of Analysis (COA) provides researchers with definitive verification of peptide identity, purity, and safety profiles. For high-precision laboratory investigations involving growth hormone regulation, evaluating HPLC chromatograms, mass spectrometry profiles, and endotoxin levels is essential prior to assay initiation.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

A lot-specific Certificate of Analysis (COA) provides researchers with definitive verification of peptide identity, purity, and safety profiles. For high-precision laboratory investigations involving growth hormone regulation, evaluating HPLC chromatograms, mass spectrometry profiles, and endotoxin levels is essential prior to assay initiation.

Reviewed by PX1 Research scientific team

Key takeaways

  • [Tesamorelin](/research-peptides/tesamorelin) is a synthetic 44-amino acid polypeptide analog of growth-hormone-releasing hormone (GHRH) modified with a trans-3-hexenoic acid group at the N-terminus.
  • High-Performance Liquid Chromatography (HPLC) serves as the industry standard for quantifying peptide purity and identifying sequence-related impurities.
  • While HPLC confirms peptide purity by separating components, Mass Spectrometry (MS) confirms molecular identity by determining exact molecular mass.
  • Bacterial endotoxins—lipopolysaccharides (LPS) derived from Gram-negative bacterial cell walls—pose a severe confounding variable in biological research.

The Role of Tesamorelin in Preclinical Endocrinological Research

Tesamorelin is a synthetic 44-amino acid polypeptide analog of growth-hormone-releasing hormone (GHRH) modified with a trans-3-hexenoic acid group at the N-terminus. This structural modification enhances its metabolic stability and resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4) compared to native GHRH. In laboratory settings, researchers utilize Tesamorelin as a primary research compound to investigate pituitary somatotroph stimulation, pulsatile growth hormone (GH) secretion, and downstream insulin-like growth factor 1 (IGF-1) signaling cascades.

Preclinical studies suggest that Tesamorelin selective binding to the GHRH receptor triggers intracellular cyclic adenosine monophosphate (cAMP) accumulation, simulating physiological axis signaling. Investigations in rodent models and cell culture frameworks focus on its capacity to support metabolic regulation, lipid turnover, hepatic fat clearance, and tissue-repair research mechanisms. To ensure reproducible baseline data in these complex metabolic assays, utilizing material backed by rigorous research peptide testing standards is critical.

High-Performance Liquid Chromatography (HPLC) Purity Verification

High-Performance Liquid Chromatography (HPLC) serves as the industry standard for quantifying peptide purity and identifying sequence-related impurities. When evaluating a Tesamorelin COA, researchers should analyze the reverse-phase HPLC (RP-HPLC) chromatogram, which utilizes a C18 stationary phase and a gradient elution buffer (typically water/acetonitrile containing trifluoroacetic acid) to resolve compound fragments.

Purity is calculated via peak area integration at a target UV absorption wavelength (commonly 214 nm or 220 nm, where peptide bonds absorb strongly). A compliant lot of PX1 Research Tesamorelin must demonstrate a major peak representing greater than or equal to 98.0% of the total integrated area. Deletion sequences, truncated fragments, oxidation products, and unreacted protecting groups appear as minor secondary peaks; verifying their absence ensures that experimental variables in cellular activation assays are strictly controlled.

Mass Spectrometry (MS) Confirmation for Molecular Mass Identity

While HPLC confirms peptide purity by separating components, Mass Spectrometry (MS) confirms molecular identity by determining exact molecular mass. Tesamorelin possesses a theoretical chemical formula of C221H366N72O67S1 and a calculated monoisotopic mass of approximately 5135.9 Da. A robust COA must include an Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) spectrum displaying the expected mass-to-charge (m/z) ratios.

In ESI-MS profiles, Tesamorelin frequently yields multiply charged species, such as [M+4H]4+, [M+5H]5+, and [M+6H]6+ ions. Deconvolution of these signals yields the observed molecular mass, which must fall within a narrow tolerance window (typically ±1.0 Da) of the theoretical mass. Matching the observed mass against theoretical calculations confirms correct amino acid assembly and successful coupling of the N-terminal trans-3-hexenoic acid moiety, ruling out erroneous sequences.

Endotoxin Quantification and Microbiological Quality Control

Bacterial endotoxins—lipopolysaccharides (LPS) derived from Gram-negative bacterial cell walls—pose a severe confounding variable in biological research. In vitro cell cultures exposed to endotoxin contamination undergo non-specific inflammatory signaling via Toll-like receptor 4 (TLR4), masking intended GHRH receptor pathways. Likewise, in vivo rodent studies can exhibit acute-phase immune responses, fever, or vascular changes if injected with contaminated peptide preparations.

PX1 Research enforces strict limits on residual endotoxin levels via Limulus Amebocyte Lysate (LAL) kinetic chromogenic testing in an ISO 17025 accredited laboratory environment. A standard COA explicitly reports endotoxin values in Endotoxin Units per milligram (EU/mg). For precision research applications, levels are held below strictly defined thresholds (typically <1.0 EU/mg or <0.1 EU/mg depending on lot specification), ensuring that experimental outcomes reflect genuine peptide-receptor interactions rather than immune activation. Explore our overarching endotoxin testing protocols for detailed analytical parameters.

Physical Attributes: Appearance, Solubility, and Residual Moisture

A comprehensive Certificate of Analysis documents physical parameters alongside chromatographic data. Lyophilized Tesamorelin should appear as a white to off-white, uniform, cake-like plug or powder. Physical discoloration or collapsed cakes may indicate improper freezing during the lyophilization cycle, excessive residual moisture, or premature thermal degradation.

Residual moisture is quantified via Karl Fischer volumetric titration or loss on drying (LOD). Controlling water content (typically target <5.0%) is critical to preventing hydrolytic cleavage of peptide bonds during storage. Additionally, initial solubility verification ensures the lyophilized cake rapidly reconstitutes into a clear, colorless solution in standard laboratory diluents without visible particulate matter or persistent aggregation.

Comparative Analysis: Tesamorelin vs. Related Secretagogue Classes

When designing protocols around somatotropic activation, laboratory researchers often compare Tesamorelin against other GHRH analogs and growth hormone secretagogues. Structural differences among these compounds influence receptor affinity, half-life, and downstream enzymatic resistance in preclinical models.

For instance, while Tesamorelin incorporates a hexenoic acid modification on the full 44-amino acid sequence, CJC-1295 DAC utilizes a modified 29-amino acid chain paired with a Drug Affinity Complex that covalently binds plasma albumin in rodent models. Conversely, Sermorelin represents the truncated native 1-29 sequence without fatty acid modifications, resulting in a significantly shorter circulating half-life in vitro. Researchers evaluating growth hormone secretagogue receptor (GHSR-1a) signaling rather than GHRH receptor pathways frequently select ghrelin mimetics like Ipamorelin. Comparing lot-specific COAs across these related peptides ensures consistent stoichiometry and signal intensity across experimental arms.

Reading and Validating a PX1 Research Certificate of Analysis

To verify authenticity and maintain rigorous compliance, researchers should systematically review the structural components of every PX1 Research documentation package. Each COA is tied directly to a specific production lot number matching the vial label. Key sections include:

1. **Header Identification:** Confirms product name, lot number, manufacture date, retest date, and molecular formula. 2. **Purity Assay (RP-HPLC):** Provides raw chromatograms, retention times, main peak areas, and calculated purity percentages. 3. **Mass Spectroscopy Data:** Includes m/z spectrum with calculated vs. observed mass comparisons. 4. **Endotoxin & Bioburden Limits:** Displays quantified LAL test results alongside acceptable threshold standards. 5. **Sign-off Credentials:** Signed by an independent ISO 17025 certified quality manager verifying raw data accuracy.

Access complete analytical records directly through our PX1 Research Library or set up institutional ordering requirements through our wholesale research portal.

Handling, Storage, and Laboratory Reconstitution Protocols

Maintaining the integrity documented on a Tesamorelin COA requires proper handling upon arrival at the research facility. Lyophilized vials are shipped under climate-controlled conditions to protect against extreme ambient temperatures. Upon receipt, unopened vials should be stored in a desiccated environment at -20°C or -80°C for long-term stability.

Prior to experimental use, vials should be allowed to equilibrate to room temperature before reconstitution to prevent moisture condensation inside the container. Reconstitution should be performed under a laminar flow hood using sterile laboratory-grade diluents, such as bacteriostatic water containing 0.9% benzyl alcohol or sterile phosphate-buffered saline (PBS), depending on downstream cell culture compatibility. Gentler swirly mixing is recommended; vigorous agitation can induce shear stress, leading to peptide aggregation or secondary structure denaturation.

Frequently Asked Questions

What is the standard purity threshold documented on a Tesamorelin COA?

PX1 Research requires a minimum HPLC purity threshold of ≥98.0% for all Tesamorelin research lots, with exact percentages documented on the lot-specific COA.

How does Mass Spectrometry confirm the structure of Tesamorelin?

Mass Spectrometry calculates the precise molecular mass (monoisotopic ~5135.9 Da). Matching the observed m/z peaks to theoretical calculations confirms correct amino acid sequence and hexenoic acid coupling.

Why are endotoxin limits reported on the COA?

Bacterial endotoxins trigger inflammatory pathways (e.g., TLR4 activation) that interfere with metabolic and somatotroph receptor signaling assays. Testing via LAL assay ensures endotoxin levels remain below strict threshold limits.

Are PX1 Research Certificates of Analysis batch-specific?

Yes. Every COA issued by PX1 Research corresponds directly to a specific synthesis and lyophilization lot, displaying unique HPLC chromatograms and mass spectra.

Where is PX1 Research Tesamorelin synthesized and tested?

PX1 Research compounds are USA-synthesized in GMP-compliant facilities and undergo independent analytical testing at ISO 17025 accredited laboratories.

How should reconstituted Tesamorelin be stored in the lab?

Once reconstituted with an appropriate sterile solvent, liquid aliquots should be kept at 2°C to 8°C for short-term use or frozen at -20°C to prevent degradation, avoiding repeated freeze-thaw cycles.

What solvent is recommended for reconstituting lyophilized Tesamorelin?

Common laboratory diluents include sterile bacteriostatic water (containing 0.9% benzyl alcohol) for multi-use laboratory procedures or sterile 0.9% sodium chloride/PBS for sensitive cell culture assays.

How does Tesamorelin differ structurally from native GHRH?

Tesamorelin contains the complete 44-amino acid structure of native GHRH with an attached trans-3-hexenoic acid group at its N-terminus, which protects against rapid DPP-4 cleavage in experimental media.

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.